Multinational firms rapidly expanding domestic share

Published: 2003-01-16 07:00:00

Updated: 2003-01-16 07:00:00

Business sources say that amid the government's sustained drug-related policies in favor of drug price reduction and Korean doctors' preference on high-priced original drugs, the increasing market share of multinational firms in domestic pharmaceutical market is apt to substantially reduce Korea ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK